Cardiac Science Announces Registration Of Shares

BOTHELL, Wash., Dec. 7 /PRNewswire-FirstCall/ -- Cardiac Science Corporation , a global leader in advanced diagnostic cardiology and automated external defibrillation products (“AEDs”), today announced that it has filed a registration statement on Form S-3 with the Securities and Exchange Commission to register for resale approximately 3.3 million shares of the company’s common stock that are owned by certain security holders, including affiliates of Perseus, LLC, or are issuable on exercise of warrants held by those holders. These warrants were issued by Cardiac Science, Inc. (“CSI”) in financing and other transactions that occurred prior to the merger of CSI and Quinton Cardiology Systems, Inc. (“Quinton”) on September 1, 2005.

(Logo: http://www.newscom.com/cgi-bin/prnh/20050913/SFTU139LOGO )

This registration statement was filed pursuant to a contractual obligation arising in connection with the recently completed merger of Quinton and CSI, under which affiliates of Perseus, LLC (collectively “Perseus”) converted CSI notes and warrants into cash and shares of the newly formed Cardiac Science Corporation. Pursuant to the agreement with Perseus, a representative of Perseus remains on the board of directors of Cardiac Science Corporation.

About Cardiac Science Corporation

Cardiac Science Corporation develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators, electrocardiographs, stress test systems, Holter monitoring systems, hospital defibrillators, cardiac rehabilitation telemetry systems, patient monitor -- defibrillators and cardiology data management systems. Cardiac Science Corporation also sells a variety of related products and consumables, and provides a comprehensive portfolio of training, maintenance and support services.

The company is the successor to various entities that have owned and operated cardiology related businesses, which sold products under the trusted brand names Burdick(R), Powerheart(R), and Quinton(R). Cardiac Science Corporation is headquartered in Bothell, WA, and also has operations in Lake Forest, California, Deerfield, Wisconsin, Shanghai, China, Copenhagen, Denmark and Manchester, United Kingdom.

Contact: Mike Matysik, senior vice president and chief financial officer (425) 402-2009 www.cardiacscience.com

Photo: http://www.newscom.com/cgi-bin/prnh/20050913/SFTU139LOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk photodesk@prnewswire.comCardiac Science Corporation

CONTACT: Mike Matysik, senior vice president and chief financial officerof Cardiac Science Corporation, +1-425-402-2009

MORE ON THIS TOPIC